Patrick Connor Johnson

26PUBLICATIONS

153CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHaematologyChemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 30, 2026

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Apr 07, 2026

Beyond age: Frailty-guided care in hematologic malignancies.

Reed Friend, P Connor Johnson, Daphne Campbell

|Feb 11, 2026

Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Lea Mantz, P Connor Johnson, Matthew Lei

|Jan 27, 2026

Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Oct 31, 2025

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Oct 29, 2025

Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia.

Bruce E Sands, Anuradha S Shenoy-Bhangle, Jacob E Lemieux

Pageof 5

Frequent Collaborators

Areej El-Jawahri

Jeffrey A Barnes

Jeremy S Abramson

Ashley M Nelson

Jacob D Soumerai

Hermioni L Amonoo

Philipp Karschnia

Marcela V Maus

Tejaswini M Dhawale

Matthew M Lei

Frequent Collaborators

Areej El-Jawahri

Jeffrey A Barnes

Jeremy S Abramson

Ashley M Nelson